Image

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

RESOLVE-AF: Testing a new system to help treat atrial fibrillation.

Recruiting
18-80 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study tests a special tool called the Ablacath™ Mapping Catheter and the Ablamap® System to help treat atrial fibrillation (AF). AF is a condition where the heart beats irregularly. The study aims to show how safe and effective these tools are by checking them in up to 400 patients from 25 places worldwide. Patients must be suitable for heart mapping and ablation, which is a treatment to fix heart rhythm problems. They need to be over 18 and meet certain heart size requirements.

Some people can’t join, like those with reversible AF, recent heart surgery, or certain heart conditions. The study involves a 12-month follow-up after the treatment. Participants will have their heart's electric signals mapped to guide the treatment.

  • The study lasts for 12 months with follow-ups.
  • Up to 400 subjects will participate globally.
  • Participants must not have certain heart conditions or recent surgeries.
Print
Study details
    Atrial Fibrillation
    Atrial Fibrillation
    Persistent
    Atrial Fibrillation Paroxysmal
    Arrhythmia
    Arrhythmias
    Cardiac
    Atrial Flutter
    Atrial Fibrillation
    Paroxysmal or Persistent
    Atrial Arrhythmia
    Atrial Tachycardia

NCT05883631

Cortex

3 November 2024

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.